Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-062 - KRAS Mutations (KRAS-Mut) and antiPD1/PDL1 Therapy in a Cohort of Lung Cancer (LC) Patients (P). Experience from a Single Institution
09:30 - 09:30 | Presenter: Enric Carcereny | Author(s): T. Morán, L. Vila, I. Teruel, C. Erasun, L. Angelats, S. España, C. Marc, N. Garcia-Balaña, J.M. Velarde
- Abstract
Loading...
-
+
P1.05 - Early Stage NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Early Stage NSCLC
-
+
P1.05-015 - Major Pathological Response as a Predictive Value of Survival in Early-Stage NSCLC After Chemotherapy: Cohort of NATCH Phase III Trial
09:30 - 09:30 | Presenter: Enric Carcereny | Author(s): A. Martinez, J.L. Mate, J. Sansano, N. Pardo, A. Estival, A. Navarro, A. Martinez De Castro, J. Zeron-Medina, L. Romero Vielva, T. Morán, S. Cedres, Enriqueta Felip
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-022 - Nintedanib/Docetaxel Efficacy in Advanced Lung Adenocarcinoma Treated with 1L Chemotherapy/2L Immunotherapy in Nintedanib NPU
09:00 - 09:00 | Presenter: Jesus Corral | Author(s): Margarita Majem, D. Rodríguez-Abreu, Enric Carcereny, Angel Artal Cortes, M. Llorente, J.M. López Picazo, Y. García, M. Domine, M.P. Lopez Criado
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-041 - Immuno-Related Cutaneous Adverse Events (IRcutAEs) in Patients (P) with Advanced NSCLC: A Single-Institution Prospective Study
09:30 - 09:30 | Presenter: Enric Carcereny | Author(s): A. Boada, R. Blanco, R. Marsé, N. Rivera, Margarita Majem, J. Terrasa, Y. García, J. Coves, A. Estival, E. Dalmau, L. Vila, P. Riera, T. Morán
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-073 - TPX-0005 with an EGFR Tyrosine Kinase Inhibitor (TKI) Overcomes Innate Resistance in EGFR Mutant NSCLC
09:30 - 09:30 | Presenter: Rafael Rosell | Author(s): Niki Karachaliou, J. Jean Cui, I. Chaib, J. Berenguer, J. Bratch, X. Li, J. Yang, A. Drozdowskyj, C. Codony Servat, J. Codony Servat, A. Giménez-Capitán, S. Viteri, Miguel-Angel Molina-Vila, G. López-Vivanco, A. Vergnenegre, José Miguel Sánchez-Torres, M. Provencio, F. De Marinis, A. Passaro, Enric Carcereny, Noemi Reguart, Rosario García Campelo, S. Ignatius Ou, Andrés F. Cardona, P. Cao
- Abstract
Loading...
-
+
OA 17 - Immunotherapy II
- 14:30 - 16:15
- 10/18/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Immunology and Immunotherapy
- Moderators:Yuichiro Ohe, Anne Tsao
-
+
OA 17.02 - Updated Efficacy Results From the BIRCH Study: First-Line Atezolizumab Therapy in PD-L1–Selected Patients With Advanced NSCLC
14:40 - 14:50 | Presenter: Enric Carcereny | Author(s): Enriqueta Felip, Martin Reck, J. Patel, R. Heist, A. Balmanoukian, Laura Q Chow, Luis Paz-Ares, J. Qiu, S. Coleman, S. Mocci, A. Sandler, T. Kurata, Frances A Shepherd
- Abstract
Loading...